Segment Information (Tables)

6 Months Ended

Jun. 30, 2019

Selected Financial Info by Reportable Segment

Selected financial information by reportable segment is presented below (in thousands):



	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Revenues, net:
Prescription Pharmaceuticals	$	158,379		$	172,163		$	306,394		$	336,464
Consumer Health	19,678			18,781			37,534			38,543
Total revenues, net	178,057			190,944			343,928			375,007

Gross Profit:
Prescription Pharmaceuticals	59,785			73,286			105,228			146,794
Consumer Health	8,199			7,993			16,269			16,713
Total gross profit	67,984			81,279			121,497			163,507

Operating expenses	155,350			172,445			274,346			280,088

Operating (loss)	(87,366		)	(91,166		)	(152,849		)	(116,581		)

Other expenses, net	(22,751		)	(13,090		)	(38,029		)	(23,702		)

(Loss) before income taxes	$	(110,117	)	$	(104,256	)	$	(190,878	)	$	(140,283	)

Revenue from External Customers by Geographic Areas

The following table sets forth the Company’s net revenues by geographic region for the three and six month periods ended June 30, 2019 and 2018. The Domestic region represents sales within the United States of America and its territories while the Foreign region represents sales within all other countries and territories (dollar amounts in thousands):



	Three Months Ended June 30, 2019			Three Months Ended June 30, 2018			Six Months Ended June 30, 2019			Six Months Ended June 30, 2018
Region	Amount		% of Total Revenues	Amount		% of Total Revenues	Amount		% of Total Revenues	Amount		% of Total Revenues
Domestic	$	174,109	97.8%	$	186,726	97.8%	$	338,243	98.3%	$	367,740	98.1%
Foreign	3,948		2.2%	4,218		2.2%	5,685		1.7%	7,267		1.9%
Total Revenues	$	178,057	100.0%	$	190,944	100.0%	$	343,928	100.0%	$	375,007	100.0%